The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Kyomen, H. H.
* Articles by Wei, J. Y.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Kyomen, H. H.
* Articles by Wei, J. Y.
Related Collections
* Neuroendocrinology
* Geriatric Psychiatry
* Dementias (General)
* Symptoms/Dimensions
Am J Psychiatry 159:1225-1227, July 2002
© 2002 American Psychiatric Association


Brief Report

Estrogen Therapy and Noncognitive Psychiatric Signs and Symptoms in Elderly Patients With Dementia

Helen H. Kyomen, M.D., M.S., John Hennen, Ph.D., Gary L. Gottlieb, M.D., M.B.A., and Jeanne Y. Wei, M.D., Ph.D.

OBJECTIVE: This study investigated the efficacy and safety of short-term estrogen therapy in decreasing noncognitive signs and symptoms of dementia in demented elderly patients. METHOD: Sixteen moderately to severely demented elderly patients with aggressive behavioral disturbances were randomly assigned to receive conjugated equine estrogens or placebo in a 4-week clinical trial. Frequency and severity of noncognitive signs and symptoms of dementia, as assessed with the Dementia Signs and Symptoms Scale, were compared between estrogen and placebo groups. Data were analyzed with intent-to-treat and regression modeling methods. RESULTS: Estrogen therapy was associated with a significantly greater improvement on the Dementia Signs and Symptoms Scale total score than placebo. All five Dementia Signs and Symptoms Scale subscale comparisons favored estrogen therapy. No adverse effects were observed. CONCLUSIONS: These preliminary data suggest that short-term estrogen therapy may safely decrease the frequency and severity of noncognitive signs and symptoms of dementia in elderly patients.




This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. M. Kenny, G. Fabregas, C. Song, B. Biskup, and S. Bellantonio
Effects of Testosterone on Behavior, Depression, and Cognitive Function in Older Men With Mild Cognitive Loss
J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2004; 59(1): M75 - 78.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
G. T. Grossberg and A. K. Desai
Management of Alzheimer's Disease
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): M331 - 353.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org